frederique Penault-llorca
机构: PU-PH anatomie et cytologie pathologiques, université Clermont Auvergne
每年引用次数
引用次数
引用: 63,667
H-指数: 105
I10-指数 : 380
出版物: 1,062
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice
Sandra Dupouy , Van Kien Doan , Zherui Wu , Najat Mourra
Oncotarget 5 ( 18) 8235 -8251
28
2014
Le PAIR-gynécologie : recherche multi/interdisciplinaire en cancérologie gynécologique. Les problèmes à résoudre en 2012
Isabelle Ray-Coquard , Franck Chauvin , Éric Leblanc , Christophe Caux
Bulletin Du Cancer 99 ( 4) 479 -498
2
2012
Resistance to human epidermal growth factor receptor type 2-targeted therapies
Jean-Christophe Thery , Jean-Philippe Spano , David Azria , Eric Raymond
European Journal of Cancer 50 ( 5) 892 -901
38
2014
When to do surgical resection for atypical breast lesions: Results of a prospective cohort of 518 lesions.
Monique Cohen , Simon Benhaim , Aurélie Jalaguier Coudray , Marie Pierre Chauvet
Surgical Oncology-oxford 34 80 -85
2020
Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
Gilles Houvenaeghel , Jean-Marc Classe , Jean-Rémy Garbay , Sylvia Giard
The Breast 23 ( 5) 561 -566
26
2014
Predominance of BRCA2 mutation and estrogen receptor positivity in unselected breast cancer with BRCA1 or BRCA2 mutation
Pascal Pujol , Kevin Yauy , Amandine Coffy , Nicolas Duforet-Frebourg
Cancers 14 ( 13) 3266 -3266
6
2022
[ASCO 2005: biology has spoken!].
Frédérique Penault‐Llorca , Jacques‐Olivier Bay
Bulletin Du Cancer 92 ( 7) 623 -624
1
2005
Modification des glycoconjugués au cours du processus de cancérisation : cas des carcinomes mammaires
Grazyna Konska , Frédérique Penault‐Llorca , Florence Caldefie‐Chezet , Monique de Latour
Bulletin Du Cancer 91 ( 2) 141 -158
11
2004
Pathological and Clinical Response of a Primary Chemotherapy Regimen Combining Vinorelbine, Epirubicin, and Paclitaxel as Neoadjuvant Treatment in Patients with Operable Breast Cancer
Catherine Abrial , Isabelle Van Praagh , Rémi Delva , Bernard Leduc
Oncologist 10 ( 4) 242 -249
11
2005
Achieving higher pathological complete response rates in HER-2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer.
Hervé Curé , Philippe Chollet , Frédérique Penault‐Llorca , Catherine Abrial
Oncologist 12 ( 4) 390 -396
12
2007
Changes in and Prognostic Value of Hormone Receptor Status in a Series of Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Olivier Tacca , Frédérique Penault‐Llorca , Catherine Abrial , Marie‐Ange Mouret‐Reynier
Oncologist 12 ( 6) 636 -643
63
2007
Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Frédérique Penault‐Llorca , Catherine Abrial , Inès Raoelfils , Philippe Chollet
Oncologist 13 ( 12) 1235 -1245
88
2008
ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis
Mathilde Gay‐Bellile , Pierre Romero , Anne Cayre , Lauren Véronèse
The Journal of Pathology: Clinical Research 2 ( 4) 234 -246
11
2016
Modification of glycoconjugates during the carcinogenesis: the case of mammary carcinomas
Jean Guillot , Margaret Guerry , Grazyna Konska , Florence Caldefie‐Chezet
Bulletin du cancer 91 ( 2) 141 -158
23
2004
MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patients
Josien C Haan , Rajith Bhaskaran , Architha Ellappalayam , Yannick Bijl
Genes, Chromosomes and Cancer 61 ( 3) 148 -160
16
2022
Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study
Marine Jary , Wen‐wei Liu , Dongyao Yan , Isaac Bai
Molecular Oncology 16 ( 11) 2260 -2273
7
2022
ASCO 2005: la biologie a parlé¡
Frédérique Penault‐Llorca , Jacques‐Olivier Bay
Bulletin du cancer 92 ( 7) 623 -624
1
2005
HER2: nos certitudes seraient‐elles en train de s’ ébranler?
Frédérique Penault‐Llorca
Bulletin du cancer 92 ( 4) 299 -300
2005
Molecular Ultrasound Imaging Using Contrast Agents Targeting Endoglin, Vascular Endothelial Growth Factor Receptor 2 and Integrin
Ingrid Leguerney , Jean-Yves Scoazec , Nicolas Gadot , Nina Robin
Ultrasound in Medicine & Biology 41 ( 1) 197 -207
22
2015
Stage I ovarian carcinoma: different clinical pathologic patterns
Liane Deligdisch , Frédérique Pénault-Llorca , Peter Schlosshauer , Albert Altchek
Fertility and Sterility 88 ( 4) 906 -910
40
2007